<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RM Global BioAccess Fund Management, LLC]]></title><description><![CDATA[RM Global BioAccess Test]]></description><link>https://www.globalbioaccess.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Tue, 10 Nov 2026 21:28:54 GMT</lastBuildDate><atom:link href="https://www.globalbioaccess.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Cardiovascular Drug Development Funding for Early-Stage Programs: Rationale, Stage, and IND Capital Needs]]></title><link>https://www.globalbioaccess.com/post/cardiovascular-drug-development-funding-for-early-stage-programs-rationale-stage-and-ind-capital</link><guid isPermaLink="false">6af38a45207895489946d5db</guid><pubDate>Tue, 10 Nov 2026 21:19:14 GMT</pubDate><dc:creator>PIMM Wix Team</dc:creator></item></channel></rss>